Cargando…
Rapid induction of p62 and GABARAPL1 upon proteasome inhibition promotes survival before autophagy activation
Proteasome inhibitors are used as research tools and to treat multiple myeloma, and proteasome activity is diminished in several neurodegenerative diseases. We therefore studied how cells compensate for proteasome inhibition. In 4 h, proteasome inhibitor treatment caused dramatic and selective induc...
Autores principales: | Sha, Zhe, Schnell, Helena M., Ruoff, Kerstin, Goldberg, Alfred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940303/ https://www.ncbi.nlm.nih.gov/pubmed/29535191 http://dx.doi.org/10.1083/jcb.201708168 |
Ejemplares similares
-
p62 links the autophagy pathway and the ubiqutin–proteasome system upon ubiquitinated protein degradation
por: Liu, Wei Jing, et al.
Publicado: (2016) -
The transcription factor NRF1 (NFE2L1) activates aggrephagy by inducing p62 and GABARAPL1 after proteasome inhibition to maintain proteostasis
por: Hatanaka, Atsushi, et al.
Publicado: (2023) -
The autophagy GABARAPL1 gene is epigenetically regulated in breast cancer models
por: Hervouet, Eric, et al.
Publicado: (2015) -
p62 at the crossroad of the ubiquitin-proteasome system and autophagy
por: Cohen-Kaplan, Victoria, et al.
Publicado: (2016) -
A new crystal form of GABARAPL2
por: Scicluna, Kristen, et al.
Publicado: (2021)